価格表

在庫・価格 : 2024年04月19日 08時25分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-SALL4, Mouse-Mono(6E3)
データシート※最新のデータシートでない場合があります
H00057167-M03 ABNアブノヴァ
Abnova Corporation
100 μg ¥72,000 2個 追加

在庫・価格 : 2024年04月19日 08時25分 現在

Anti-SALL4, Mouse-Mono(6E3)

  • 商品コード:H00057167-M03
  • メーカー:ABN
  • 包装:100μg
  • 価格: ¥72,000
  • 在庫:2個
使用文献
No. 文献情報 備考 参照
1 Cauffman G et al. Markers that define stemness in ESC are unable to identify the totipotent cells in human preimplantation embryos. Hum. Reprod. 2009 Jan;24(1):63-70
Cauffman G et al
2009/01/01
PubMed
2 Forte A et al. Expression pattern of stemness-related genes in human endometrial and endometriotic tissues. Mol. Med. ;15(11-12):392-401
Forte A et al
PubMed
3 Sangoi AR et al. Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases. Mod. Pathol. 2011 Mar;24(3):425-9
Sangoi AR et al
2011/01/01
PubMed
4 Deisch J et al. Immunoexpression of SALL4 in Wilms tumors and developing kidney. Pathol. Oncol. Res. 2011 Sep;17(3):639-44
Deisch J et al
2011/01/01
PubMed
5 Clark PE et al. β-Catenin and K-RAS synergize to form primitive renal epithelial tumors with features of epithelial Wilms" tumors. Am. J. Pathol. 2011 Dec;179(6):3045-55
Clark PE et al
2011/01/01
PubMed
6 Meguro S et al. α-Fetoprotein-producing ovarian tumor in a postmenopausal woman with germ cell differentiation. Ann Diagn Pathol 2011 Nov;
Meguro S et al
2011/01/01
PubMed
7 Iwamoto N et al. Mediastinal seminoma: A case report with special emphasis on sall4 as a new immunocytochemical marker. Diagn Cytopathol 2012 Feb;
Iwamoto N et al
2012/01/01
PubMed
8 Ikeda H et al. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression. Hum Pathol 2012 Apr;
Ikeda H et al
2012/01/01
PubMed
9 Ota Y et al. Metastatic seminomas in lymph nodes: CD10 immunoreactivity can be a pitfall of differential diagnosis. Int J Clin Exp Pathol 2013;6(3):498-502
Ota Y et al
2013/01/01
PubMed
10 Zeng SS et al. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma. J. Hepatol. 2014 Jan;60(1):127-34
Zeng SS et al
2014/01/01
PubMed
11 Fujimoto M et al. SALL4 immunohistochemistry in non-small-cell lung carcinomas. Histopathology 2014 Jan;64(2):309-11
Fujimoto M et al
2014/01/01
PubMed
12 Osada M et al. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma. Hum. Pathol. 2014 Jun;45(6):1243-50
Osada M et al
2014/01/01
PubMed
13 Yoshida A et al. Differential SALL4 immunoexpression in malignant rhabdoid tumours and epithelioid sarcomas. Histopathology 2015 Jan;66(2):252-61
Yoshida A et al
2015/01/01
PubMed
14 Chapman KM et al. NRG1 and KITL Signal Downstream of Retinoic Acid in the Germline to Support Soma-Free Syncytial Growth of Differentiating Spermatogonia. Cell Death Discov ;1
Chapman KM et al
PubMed
15 Murakami T et al. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases. Gastric Cancer 2016 Apr;19(2):498-507
Murakami T et al
2016/01/01
PubMed
16 Matsumoto K et al. Clinicopathological features of alpha-fetoprotein producing early gastric cancer with enteroblastic differentiation. World J. Gastroenterol. 2016 Sep;22(36):8203-10
Matsumoto K et al
2016/01/01
PubMed
17 Yoshida A et al. Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities. Mod. Pathol. 2017 Jun;30(6):797-809
Yoshida A et al
2017/01/01
PubMed
18 Tajima S et al. Germinoma with an extensive rhabdoid cell component centered at the corpus callosum. Med Mol Morphol 2017 Mar;50(1):52-58
Tajima S et al
2017/01/01
PubMed
19 Kilic E et al. The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus. Virchows Arch. 2016 Apr;468(4):483-92
Kilic E et al
2016/01/01
PubMed
20 Shi H et al. 3,3"-Diindolylmethane stimulates exosomal Wnt11 autocrine signaling in human umbilical cord mesenchymal stem cells to enhance wound healing. Theranostics 2017;7(6):1674-1688
Shi H et al
2017/01/01
PubMed
21 Machado I et al. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis. Ann Diagn Pathol 2018 Jun;34
Machado I et al
2018/01/01
PubMed
22 Fujimoto M et al. HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types. J. Clin. Pathol. 2018 Jul;71(7):600-607
Fujimoto M et al
2018/01/01
PubMed
23 Yamada R et al. Early Gastric Cancer with Purely Enteroblastic Differentiation and No Conventional Adenocarcinoma Component. Case Rep Pathol 2018;2018:3620293
Yamada R et al
2018/01/01
PubMed
24 Terada Y et al. Human Pluripotent Stem Cell-Derived Tumor Model Uncovers the Embryonic Stem Cell Signature as a Key Driver in Atypical Teratoid/Rhabdoid Tumor. Cell Rep 2019 Mar;26(10):2608-2621.e6
Terada Y et al
2019/01/01
PubMed
25 Tsuzuki S et al. A case of renal cell carcinoma unclassified with medullary phenotype without detectable gene deletion. Pathol. Int. 2019 Dec;69(12):710-714
Tsuzuki S et al
2019/01/01
PubMed
26 Murakami T et al. Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological study of five cases. Histopathology 2020 Jan;76(2):325-332
Murakami T et al
2020/01/01
PubMed
27 Ichimata S et al. A case of large cell neuroendocrine carcinoma exhibiting rhabdoid features in the esophagogastric junction. Pathol. Int. 2019 Aug;69(8):481-487
Ichimata S et al
2019/01/01
PubMed
28 Zhao B et al. Inflammatory Micro-environment Contributes to Stemness Properties and Metastatic Potential of HCC via the NF-κB/miR-497/SALL4 Axis. Mol Ther Oncolytics 2019 Dec;15:79-90
Zhao B et al
2019/01/01
PubMed
29 Zhao B et al. Ku80 negatively regulates the expression of OCT4 via competitive binding to SALL4 and promoting lysosomal degradation of OCT4. Int J Biochem Cell Biol 2020 01;118:105664
Zhao B et al
2020/01/01
PubMed
30 Ikezawa N et al. Early gastric cancer involving a pure enteroblastic differentiation component that was curatively resected via endoscopic submucosal dissection. Clin J Gastroenterol 2020 Aug;13(4):512-516
Ikezawa N et al
2020/01/01
PubMed
31 Shibahara J et al., Clinicopathologic characteristics of SALL4-immunopositive hepatocellular carcinoma., SpringerPlus 2014, 3:721 doi:10.1186/2193-1801-3-721

PubMed
32 Kohashi K et al., ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor., Human Pathology(2014), doi: 10.1016/j.humpath. 2014.10.010

PubMed
33 Yonemaru J et al. A yolk sac tumor of the pancreas and derived xenograft model effectively responded to VIP chemotherapy. Pancreatology 2020 Apr;20(3):551-557
Yonemaru J et al
2020/01/01
PubMed
34 Kobayashi T et al. Neonatal streptozotocin treatment rapidly causes different subtype of hepatocellular carcinoma without persistent hyperglycemia in 4CS mice fed on a normal diet. Pathol Res Pract 2021 Sep;225:153559
Kobayashi T et al
2021/01/01
PubMed
35 Kawachi H et al. Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma. Immunotherapy 2021 07;13(10):799-806
Kawachi H et al
2021/01/01
PubMed
36 Kishikawa S et al. Distinct properties of pure- and mixed-type high-grade fetal lung adenocarcinomas by genetic profiling and transcription factor expression. Virchows Arch 2022 Mar;480(3):609-619
Kishikawa S et al
2022/01/01
PubMed
37 Shibahara J et al. Clinicopathologic characteristics of SALL4-immunopositive hepatocellular carcinoma. Springerplus 2014;3:721
Shibahara J et al
2014/01/01
PubMed
38 Kohashi K et al. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Hum. Pathol. 2015 Feb;46(2):225-30
Kohashi K et al
2015/01/01
PubMed
39 Akiyama T et al. Establishment and characterization of NCC-MRT1-C1: a novel cell line of malignant rhabdoid tumor. Hum Cell 2022 Nov;35(6):2002-2010
Akiyama T et al
2022/01/01
PubMed
40 Ota T et al. The first case of SMARCA4-deficient sarcoma of stomach. Clin J Gastroenterol 2022 Jun;15(3):531-536
Ota T et al
2022/01/01
PubMed
41 Chapman KM et al. Rattus norvegicus Spermatogenesis Colony-Forming Assays. Methods Mol Biol 2023;2677:233-257
Chapman KM et al
2023/01/01
PubMed
  • No.: 1
  • 文献情報:
    Cauffman G et al. Markers that define stemness in ESC are unable to identify the totipotent cells in human preimplantation embryos. Hum. Reprod. 2009 Jan;24(1):63-70
    Cauffman G et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Forte A et al. Expression pattern of stemness-related genes in human endometrial and endometriotic tissues. Mol. Med. ;15(11-12):392-401
    Forte A et al
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Sangoi AR et al. Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases. Mod. Pathol. 2011 Mar;24(3):425-9
    Sangoi AR et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Deisch J et al. Immunoexpression of SALL4 in Wilms tumors and developing kidney. Pathol. Oncol. Res. 2011 Sep;17(3):639-44
    Deisch J et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Clark PE et al. β-Catenin and K-RAS synergize to form primitive renal epithelial tumors with features of epithelial Wilms" tumors. Am. J. Pathol. 2011 Dec;179(6):3045-55
    Clark PE et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Meguro S et al. α-Fetoprotein-producing ovarian tumor in a postmenopausal woman with germ cell differentiation. Ann Diagn Pathol 2011 Nov;
    Meguro S et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Iwamoto N et al. Mediastinal seminoma: A case report with special emphasis on sall4 as a new immunocytochemical marker. Diagn Cytopathol 2012 Feb;
    Iwamoto N et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Ikeda H et al. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression. Hum Pathol 2012 Apr;
    Ikeda H et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Ota Y et al. Metastatic seminomas in lymph nodes: CD10 immunoreactivity can be a pitfall of differential diagnosis. Int J Clin Exp Pathol 2013;6(3):498-502
    Ota Y et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Zeng SS et al. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma. J. Hepatol. 2014 Jan;60(1):127-34
    Zeng SS et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Fujimoto M et al. SALL4 immunohistochemistry in non-small-cell lung carcinomas. Histopathology 2014 Jan;64(2):309-11
    Fujimoto M et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Osada M et al. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma. Hum. Pathol. 2014 Jun;45(6):1243-50
    Osada M et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Yoshida A et al. Differential SALL4 immunoexpression in malignant rhabdoid tumours and epithelioid sarcomas. Histopathology 2015 Jan;66(2):252-61
    Yoshida A et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Chapman KM et al. NRG1 and KITL Signal Downstream of Retinoic Acid in the Germline to Support Soma-Free Syncytial Growth of Differentiating Spermatogonia. Cell Death Discov ;1
    Chapman KM et al
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Murakami T et al. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases. Gastric Cancer 2016 Apr;19(2):498-507
    Murakami T et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Matsumoto K et al. Clinicopathological features of alpha-fetoprotein producing early gastric cancer with enteroblastic differentiation. World J. Gastroenterol. 2016 Sep;22(36):8203-10
    Matsumoto K et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Yoshida A et al. Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities. Mod. Pathol. 2017 Jun;30(6):797-809
    Yoshida A et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Tajima S et al. Germinoma with an extensive rhabdoid cell component centered at the corpus callosum. Med Mol Morphol 2017 Mar;50(1):52-58
    Tajima S et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Kilic E et al. The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus. Virchows Arch. 2016 Apr;468(4):483-92
    Kilic E et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Shi H et al. 3,3"-Diindolylmethane stimulates exosomal Wnt11 autocrine signaling in human umbilical cord mesenchymal stem cells to enhance wound healing. Theranostics 2017;7(6):1674-1688
    Shi H et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Machado I et al. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis. Ann Diagn Pathol 2018 Jun;34
    Machado I et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Fujimoto M et al. HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types. J. Clin. Pathol. 2018 Jul;71(7):600-607
    Fujimoto M et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Yamada R et al. Early Gastric Cancer with Purely Enteroblastic Differentiation and No Conventional Adenocarcinoma Component. Case Rep Pathol 2018;2018:3620293
    Yamada R et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Terada Y et al. Human Pluripotent Stem Cell-Derived Tumor Model Uncovers the Embryonic Stem Cell Signature as a Key Driver in Atypical Teratoid/Rhabdoid Tumor. Cell Rep 2019 Mar;26(10):2608-2621.e6
    Terada Y et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Tsuzuki S et al. A case of renal cell carcinoma unclassified with medullary phenotype without detectable gene deletion. Pathol. Int. 2019 Dec;69(12):710-714
    Tsuzuki S et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Murakami T et al. Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological study of five cases. Histopathology 2020 Jan;76(2):325-332
    Murakami T et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Ichimata S et al. A case of large cell neuroendocrine carcinoma exhibiting rhabdoid features in the esophagogastric junction. Pathol. Int. 2019 Aug;69(8):481-487
    Ichimata S et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Zhao B et al. Inflammatory Micro-environment Contributes to Stemness Properties and Metastatic Potential of HCC via the NF-κB/miR-497/SALL4 Axis. Mol Ther Oncolytics 2019 Dec;15:79-90
    Zhao B et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Zhao B et al. Ku80 negatively regulates the expression of OCT4 via competitive binding to SALL4 and promoting lysosomal degradation of OCT4. Int J Biochem Cell Biol 2020 01;118:105664
    Zhao B et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Ikezawa N et al. Early gastric cancer involving a pure enteroblastic differentiation component that was curatively resected via endoscopic submucosal dissection. Clin J Gastroenterol 2020 Aug;13(4):512-516
    Ikezawa N et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Shibahara J et al., Clinicopathologic characteristics of SALL4-immunopositive hepatocellular carcinoma., SpringerPlus 2014, 3:721 doi:10.1186/2193-1801-3-721

  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Kohashi K et al., ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor., Human Pathology(2014), doi: 10.1016/j.humpath. 2014.10.010

  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Yonemaru J et al. A yolk sac tumor of the pancreas and derived xenograft model effectively responded to VIP chemotherapy. Pancreatology 2020 Apr;20(3):551-557
    Yonemaru J et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Kobayashi T et al. Neonatal streptozotocin treatment rapidly causes different subtype of hepatocellular carcinoma without persistent hyperglycemia in 4CS mice fed on a normal diet. Pathol Res Pract 2021 Sep;225:153559
    Kobayashi T et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Kawachi H et al. Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma. Immunotherapy 2021 07;13(10):799-806
    Kawachi H et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Kishikawa S et al. Distinct properties of pure- and mixed-type high-grade fetal lung adenocarcinomas by genetic profiling and transcription factor expression. Virchows Arch 2022 Mar;480(3):609-619
    Kishikawa S et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Shibahara J et al. Clinicopathologic characteristics of SALL4-immunopositive hepatocellular carcinoma. Springerplus 2014;3:721
    Shibahara J et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Kohashi K et al. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Hum. Pathol. 2015 Feb;46(2):225-30
    Kohashi K et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Akiyama T et al. Establishment and characterization of NCC-MRT1-C1: a novel cell line of malignant rhabdoid tumor. Hum Cell 2022 Nov;35(6):2002-2010
    Akiyama T et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Ota T et al. The first case of SMARCA4-deficient sarcoma of stomach. Clin J Gastroenterol 2022 Jun;15(3):531-536
    Ota T et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Chapman KM et al. Rattus norvegicus Spermatogenesis Colony-Forming Assays. Methods Mol Biol 2023;2677:233-257
    Chapman KM et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed